Consistent with this theory, the present study showed that ovarian cancer tissue with hypermethylated BRCA1 promoter (Fig. 2B and Da) exhibited decreased expression of BRCA1 (Fig. 2D) when compared with adjacent normal tissue. The gene discussed is BRCA1; the disease is ovarian carcinoma.